Financing channel feed

Pre­vail grabs $75M A round in the hunt for new gene ther­a­pies to stop the de­struc­tion caused by Parkin­son's

8 years ago
Startups

SF tech start­up Atom­wise gets $45M for AI-pow­ered drug de­sign soft­ware

8 years ago
Startups
AI

Ox­ford Vacmedix moves can­cer vac­cines for­ward with $12.5M from South Ko­rea, Chi­na

8 years ago
China

Meta­vant makes a de­but: Vivek Ra­maswamy launch­es biotech #7 and builds a di­a­betes pipeline with Lig­and deal

8 years ago
Pharma

View­Point Ther­a­peu­tics gets $35M to ad­vance non-sur­gi­cal al­ter­na­tive for cataracts, pres­by­opia

8 years ago

Qui­et and con­fi­den­tial IPO reg­is­tra­tion? Who needs it. Au­to­lus shouts about its next big raise

8 years ago

Chi­nese med­i­cine play­er Tasly con­sid­ers Hong Kong IPO for its biotech arm: re­port

8 years ago
China

Gene edit­ing ex­pert Ho­mol­o­gy de­tails the num­bers in its back-end­ed $1B No­var­tis deal, files for $100M IPO

8 years ago

Is tech mon­ey bad for busi­ness? Sil­i­con Val­ley cash makes some bio­phar­ma VCs bris­tle, oth­ers cheer

8 years ago
Startups
Bioregnum

Unum plays its first glimpse of hu­man da­ta in an $86M IPO, re­veal­ing two deaths and an FDA hold

8 years ago
Startups
Pharma

Amid a bois­ter­ous fundrais­ing week, Bio­Med­Part­ners airs $107M biotech fund

8 years ago

Take­da-part­nered Finch Ther­a­peu­tics grabs $36M and looks to leapfrog the pack in mi­cro­bio­me R&D

8 years ago

PureTech's Gele­sis brings in $30M to back its FDA pitch on a new weight loss ther­a­py with trou­ble­some da­ta

8 years ago

Suck­ing up tal­ent out of No­var­tis, a boom­ing Ru­bius adds an­oth­er $100 mil­lion mega-round to the kit­ty

8 years ago

No­vo Hold­ings is look­ing for a few good su­per­bug biotechs in need of ear­ly-stage fund­ing — in­vest­ing $165M

8 years ago

Start­up mak­ing Cas9 proxy for gene edit­ing gets $55M to de­vel­op tools/soft­ware

8 years ago

As­traZeneca spins out 6 drugs and an R&D group in­to Viela Bio, which emerges with a piv­otal pro­gram and $250M

8 years ago

Dana-Far­ber’s Lau­rie Glim­ch­er helps launch a NYC biotech up­start with some key in­sights on im­muno-on­col­o­gy tech

8 years ago
Startups

Haul­ing in a $100M mega-round, gene ther­a­py start­up Gen­er­a­tion Bio builds al­ter­na­tive to po­ten­tial­ly risky vi­ral vec­tors

8 years ago
Startups
Cell/Gene Tx

Com­put­er sci­ence and en­gi­neer­ing, meet drug R&D. MIT star Tim­o­thy Lu in­ter­twines tech­nolo­gies for an off­beat biotech launch

8 years ago
Startups

Fast ex-Flexus team takes Ar­cus to a quick $100M IPO to ad­vance I/O pipeline

8 years ago

Is NYC a biotech hub? Gut-brain start­up Kally­ope, equipped with $66M in new mon­ey, says yes

8 years ago
Startups

AI start­up BioX­cel Ther­a­peu­tics shoots for $69M IPO with drugs for Alzheimer's, can­cer

8 years ago

GV-backed start­up Rani gets $53M from new in­vestors for 'ro­bot­ic pil­l'

8 years ago
First page Previous page 130131132133134135136 Next page Last page
A service from the Financial Times